XERS News and Press, Xeris Pharmaceuticals Inc. From 10/20/20

The FDA has designated Xeris Pharmaceuticals's (XERS) XP-0863 (diazepam non-aqueous injection) for fast track review for the treatment of acute repetitive seizures.XP-0863 was previously granted orphan designations both for the treatment of acute repetitive seizures and for the treatment of D...

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced it was granted Fast Track designation by the Food and Drug Admin...

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that Paul R. Edick, Chairman and Chief Executive Officer of Xeris Pha...

When It Comes To Penny Stocks To Buy, Do You Agree With These Analysts? When it comes to penny stocks , do you trust analyst ratings? Wall Street has plenty of them but different firms evoke different sentiment in some cases. Have you ever found penny stocks to trade and all of them climb aft...

Penny Stocks To Watch As The Economy Continues To Re-Open Epicenter stocks and, specifically, epicenter penny stocks have become a larger focus for some investors this year. If you’re not familiar with what epicenter stocks are, let me give you the general definition. Initially coined...

Xeris Pharmaceuticals ( XERS ) is a company that got on my radar about two weeks ago. Xeris is already a commercial stage biotech, and this past week saw a big rally in the stock as sales of its lead product, Gvoke, have started picking up. Figure 1: Xeris Stock Chart ( source: finviz ) ...

Are These Penny Stocks On Your Watch List? In 2020, penny stocks are catching the eye of many new investors. This generally refers to stocks under $5. This year has brought in an increased amount of investors into the market because of the current economic situation. Some penny stocks have b...

This article is part of a series that provides an ongoing analysis of the changes made to George Soros's 13F stock portfolio on a quarterly basis. It is based on George Soros's regulatory 13F Form filed on 08/14/2020. Please visit our Tracking Soros Fund Management Holdings article for an ...

Midatech Pharma plc (NASDAQ: MTP ) +26% . More news on: Midatech Pharma plc, Houston American Energy Corp., ShiftPixy, Inc., Stocks on the move, , Read more ...

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use (RTU) injectable and infusible drug formulations, today announced that its Board of Directors has promoted John P. Sha...